Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Grand Challenges in Biology and Biotechnology is Scopus-indexed (Q4, CiteScore 0.8). Published by Springer Science and Business Media B.V..
Checked against the index lists dated .
ISSN 2367-1017Verify ISSN ↗2367-1025Verify ISSN ↗
Publisher: Springer Science and Business Media B.V.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Applied Microbiology and Biotechnology | 118 / 134 | 12th | Q4 |
| Biotechnology | 287 / 325 | 11th | Q4 |
| Bioengineering | 156 / 168 | 7th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2025 (also 2023, 2018–2020, 2016), best quartile Q4, CiteScore 0.8.
Grand Challenges in Biology and Biotechnology is Q4 in Applied Microbiology and Biotechnology (rank 118 of 134), Q4 in Biotechnology (rank 287 of 325) and Q4 in Bioengineering (rank 156 of 168), by CiteScore 2025.
Grand Challenges in Biology and Biotechnology is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.8, quartile Q4, 12th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric.
Grand Challenges in Biology and Biotechnology is published by Springer Science and Business Media B.V. Its print ISSN is 2367-1017 and its online ISSN is 2367-1025.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Grand Challenges in Biology and Biotechnology has an h-index of 22 and a 2-year mean of 1.68 citations per paper (OpenAlex). Its Scopus CiteScore is 0.8, quartile Q4. On 2-year citations it ranks #84 of 130 Scopus journals in Applied Microbiology and Biotechnology.
Grand Challenges in Biology and Biotechnology published 34 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.